Thursday, May 05, 2016 2:50:05 PM
The bottom there was just a misread by you. Non sequitur (they weren't talking about the Liau study anymore in that highlighted section).
BCG is used to differentiate DC in Direct, but not L. But it's a minor point anyway--the main reasons L is almost certainly useless is due to the impact on DC when mixed with freeze thaw necrosed WTL. This can be curbed a bit when tumor cells are pre stressed but DCVax L has no such step. The DC in DCVax L are thus fixed in a tolerogenic state. And also there is 1:3,000 ratio of self antigens to relevant TAA in the slurry. Needle in a haystack. But even if some tiny % of the DC in DCVax L manage to load properly and are somehow able to reach maturity and are not also not phagocytized at the injection cite (at this point were talking maybe very very few--less than 0.5% I would guess), the "immune response" they may illicit will not thwart progression of disease appreciably enough, and ACTUALLY may theoretically exacerbate what appears to be PD, thus causing a worse PFS curve than control (see AV0113).
I've said all this before. Not sure if people are following what I'm saying or not at this point.
Anyway it's just money guys. Right?
"Think for yourselves and let others enjoy the privilege to do so, too."
-Voltaire
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM